Pacira | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Astellas Pharma JPY 346.04B 28.3B 2023-12
Bristol-Myers Squibb USD 8.93B 163M 2024-03
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
J&J USD 14.87B 275M 2024-03
Ligand Pharmaceuticals USD 28.1M 1.64M 2024-03
Pacira USD 119.7M 13.85M 2024-03
Perrigo USD 357.7M 69.6M 2024-03
Pfizer USD 11.5B 3.92B 2024-03
Supernus Pharmaceuticals USD 127.34M 17.35M 2024-03
Teva Pharmaceutical Industries USD 1.77B 726M 2024-03
Xeris Pharmaceuticals USD 34.67M 2.15M 2024-03
Zoetis USD 1.55B 60M 2024-03



Pacira Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.